Acadian Asset Management LLC Cytom X Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $35.4 Billion
- Q1 2025
A detailed history of Acadian Asset Management LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,234,035 shares of CTMX stock, worth $7.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,234,035
Previous 3,137,046
3.09%
Holding current value
$7.7 Million
Previous $3.23 Million
36.38%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding CTMX
# of Institutions
67Shares Held
44.2MCall Options Held
8.9KPut Options Held
47.9K-
Tang Capital Management LLC San Diego, CA6.72MShares$16 Million0.28% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$12.4 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.12MShares$12.2 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$9.35 Million0.9% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$6.73 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $157M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...